Curaleaf (OTCMKTS:CURLF) Shares Gap Up – Still a Buy?

Shares of Curaleaf Holdings, Inc. (OTCMKTS:CURLF) gapped up before the market opened on Friday . The stock had previously closed at $2.15, but opened at $2.28. Curaleaf shares last traded at $2.13, with a volume of 86,856 shares traded.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the stock. Alliance Global Partners reaffirmed a “buy” rating on shares of Curaleaf in a report on Monday, December 22nd. ATB Cormark Capital Markets raised shares of Curaleaf to an “outperform” rating in a research report on Tuesday, December 2nd. Finally, Zacks Research upgraded shares of Curaleaf from a “strong sell” rating to a “hold” rating in a research note on Thursday, January 1st. Two investment analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, Curaleaf has an average rating of “Buy”.

Curaleaf Trading Up 0.7%

The company has a current ratio of 1.52, a quick ratio of 0.76 and a debt-to-equity ratio of 1.14. The company has a market cap of $1.47 billion, a price-to-earnings ratio of -7.22 and a beta of 0.71. The firm has a 50-day moving average price of $2.36 and a 200 day moving average price of $2.61.

Curaleaf (OTCMKTS:CURLF) last announced its quarterly earnings data on Thursday, February 26th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.08) by $0.03. The firm had revenue of $333.07 million for the quarter, compared to analysts’ expectations of $328.70 million. Curaleaf had a negative return on equity of 23.17% and a negative net margin of 18.08%. As a group, sell-side analysts forecast that Curaleaf Holdings, Inc. will post -0.25 EPS for the current year.

About Curaleaf

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.